Internal Medicine, Hematology & Oncology · Salt Lake City, UT
NPI
1841440674
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2000 Circle of Hope Dr, Suite 2100
Salt Lake City, UT, 84112
Phone (801) 585-0120
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
589 services
Medicare patients, 2024
112
Average age 73
Drug cost, 2024
$4.3M
619 prescriptions
Company payments, 2025
$2,580
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tsewang Tashi was code G0316 (prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th), 225 times for 27 patients. In total Tsewang Tashi billed 589 services in 10 codes, and Medicare paid $30K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-16.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G0316 Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 225 | 27 | $23.42 | $5,269 |
| 99233 Hospital E&M - Subsequent | Facility | 112 | 30 | $92.43 | $10K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 59 | 33 | $12.87 | $759 |
| 99214 Office E&M - Established | Facility | 55 | 31 | $70.17 | $3,859 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 34 | 30 | $12.85 | $437 |
| 99214 Office E&M - Established | Office | 30 | 26 | $71.90 | $2,157 |
| 99215 Office E&M - Established | Facility | 19 | 13 | $102.71 | $1,951 |
| 99239 Hospital Discharge Management | Facility | 15 | 13 | $88.73 | $1,331 |
| 99223 Hospital E&M - Initial | Facility | 11 | 11 | $135.03 | $1,485 |
| 99204 Office E&M - New | Facility | 11 | 11 | $103.96 | $1,144 |
By year: 2022 $24K for 279 services; 2023 $12K for 131 services; 2024 $30K for 589 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tsewang Tashi prescribed most often to Medicare patients was Hydroxyurea, with 188 prescriptions and refills. In total Tsewang Tashi wrote 619 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 188 | 301 | 39 | $3,336 |
| Jakafi Ruxolitinib Phosphate | 78 | 78 | Under 11 | $1.3M |
| Acyclovir Generic | 72 | 86 | 12 | $1,128 |
| Ayvakit Avapritinib | 37 | 37 | Under 11 | $1.4M |
| Allopurinol Generic | 30 | 36 | 15 | $118 |
| Besremi Ropeginterferon Alfa-2b-Njft | 18 | 18 | Under 11 | $171K |
| Ondansetron Hcl Generic | 18 | 18 | Under 11 | $3,805 |
| Vonjo Pacritinib Citrate | 16 | 16 | Under 11 | $327K |
| Onureg Azacitidine | 12 | 12 | Under 11 | $154K |
| Anagrelide Hcl Generic | 11 | 22 | Under 11 | $891 |
| Revlimid Lenalidomide | 11 | 11 | Under 11 | $112K |
Brand drugs: - claims; generic drugs: 410 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tsewang Tashi $2,580 ($2,580 in general payments such as food, travel and fees) from 3 companies. The largest payer was Sanofi US Services Inc. with $2,580.
| Company | Payments | Amount |
|---|---|---|
| Sanofi US Services Inc. SNY | 1 | $2,580 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.